Abstract: The present invention relates to fluorene derivatives and to electronic devices in which these compounds are used as matrix material in the emitting layer and/or as hole-transport material and/or as electron-blocking or exciton-blocking material and/or as electron-transport material.
Abstract: The present invention relates to compounds which are suitable for use in electronic devices, and to electronic devices, in particular organic electroluminescent devices, comprising these compounds.
Type:
Grant
Filed:
November 27, 2013
Date of Patent:
March 12, 2019
Assignee:
Merck Patent GmbH
Inventors:
Anja Jatsch, Christof Pflumm, Amir Hossain Parham, Thomas Eberle, Philipp Stoessel, Jonas Valentin Kroeber, Rouven Linge
Abstract: The invention relates to boron-containing compounds with bicyclic structural units and to electronic devices, in particular organic electroluminescent devices, containing said compounds.
Abstract: The present application relates to spirobifluorene derivatives of a formula (I), to the use thereof in electronic devices, especially in organic electroluminescent devices (OLEDs), where they may be used in hole-transporting function, and to processes for preparing said derivatives. The compounds have one or more properties selected from very good hole-conducting properties, very good electron-blocking properties, high glass transition temperature, high oxidation stability, good solubility and high thermal stability.
Type:
Grant
Filed:
December 8, 2015
Date of Patent:
March 5, 2019
Assignee:
Merck Patent GmbH
Inventors:
Jochen Pfister, Frank Stieber, Elvira Montenegro, Teresa Mujica-Fernaud
Abstract: Metal complexes containing one or more amidoimine ligands, methods of making such metal complexes, and methods of using such metal complexes to prepare metal-containing films are provided.
Type:
Grant
Filed:
October 24, 2014
Date of Patent:
March 5, 2019
Assignee:
MERCK PATENT GMBH
Inventors:
Ravi Kanjolia, Shaun Garratt, David Thompson, Jeffrey Anthis
Abstract: A method of producing mixtures of interference pigments having special effects comprises mixing at least one large particle size interference pigment with at least one normal size interference pigment of predetermined colors and in proportions desired to obtain a unique effect.
Abstract: This application is directed to the use of biomarkers for predicting the sensitivity to treatment with an FGF-18 compound of a patient having a cartilage disorder, such as osteoarthritis, cartilage injury, fractures affecting joint cartilage or surgical procedures with impact on joint cartilage (e.g., microfracture), in order to reduce the risk of adverse events and increase the overall benefit after therapy.
Type:
Grant
Filed:
August 5, 2013
Date of Patent:
March 5, 2019
Assignee:
MERCK PATENT GMBH
Inventors:
Christoph Hubertus Ladel, Alix Anne Simone Berton, Armand Valsesia, Pierre Jacques Farmer
Abstract: The present invention relates to formulations for the preparation of organic electronic devices which comprise at least one specific A/JV-dialkylaniline and at least one organic functional material selected from organic conductors, organic semiconductors, organic fluorescent compounds, organic phosphorescent compounds, organic light-absorbent compounds, organic light-sensitive compounds, organic photosensitisation agents and other organic photoactive compounds, selected from organometallic complexes of transition metals, rare earths, lanthanides and actinides.
Abstract: The invention relates to a liquid-crystalline medium which comprises at least one compound of the formula I, in which R1, R1*, Z1, Z2 and L1-3 have the meanings defined herein, and to the use thereof for an active-matrix display, in particular based on the VA, PSA, PS-VA, PALC, FFS, PS-FFS, PS-IPS or IPS effect.
Type:
Grant
Filed:
June 16, 2015
Date of Patent:
February 26, 2019
Assignee:
MERCK PATENT GMBH
Inventors:
Harald Hirschmann, Monika Bauer, Martina Windhorst, Marcus Reuter, Constanze Brocke, Rocco Fortte, Matthias Bremer, Sabine Schoen
Abstract: The present invention provides a liquid-crystal display device capable of maintaining a high voltage holding ratio even without an alignment film. The liquid-crystal display device of the present invention includes a pair of substrates, a liquid crystal layer which is sandwiched between the substrates and which contains a liquid crystal material, and a polymer layer which is disposed on a surface of each of the substrates and which controls the alignment of liquid crystal molecules. The outermost surfaces of both the substrates comprise substantially no alignment film. The polymer layer is formed by polymerizing one or more radical polymerizable monomer species added to the liquid crystal layer. At least one species of the one or more radical polymerizable monomer species is a biphenyl compound having a specific structure.
Abstract: The invention relates to a liquid-crystalline medium which comprises at least one compound of the formula I, in which R1, R1*, Z1, Z2 and L1-3 have the meanings defined herein, and to the use thereof for an active-matrix display, in particular based on the VA, PSA, PS-VA, PALC, FFS, PS-FFS, PS-IPS or IPS effect.
Type:
Grant
Filed:
October 2, 2017
Date of Patent:
February 26, 2019
Assignee:
MERCK PATENT GMBH
Inventors:
Harald Hirschmann, Monika Bauer, Martina Windhorst, Marcus Reuter, Constanze Brocke, Rocco Fortte, Matthias Bremer, Sabine Schoen
Abstract: The present invention relates to thermally conductive pigments which consist of a substrate and a coating applied thereto comprising aluminum oxide and/or aluminum oxide hydrate, to a process for the preparation of these pigments, and to the use thereof.
Abstract: The present invention relates to compounds comprising a heterocyclic group substituted with a fluoranthene group and a particular aromatic or heteroaromatic group. The compounds are suitable for use in electronic devices, in particular organic electroluminescent devices, comprising these compounds. In some embodiments, the compounds are used as matrix materials for phosphorescent or fluorescent emitters as well as a hole-blocking or an electron-transport layer.
Type:
Application
Filed:
October 6, 2016
Publication date:
February 21, 2019
Applicant:
Merck Patent GmbH
Inventors:
Amir Hossain PARHAM, Tobias GROSSMANN, Jonas Valentin KROEBER
Abstract: A sample preparation container, preferably for use in sterility testing, comprising a housing (1) having a housing wall (2) defining an inside space (3), a support on which a membrane filter is placed or is to be placed so as to get in contact with a sampling fluid to be introduced into the inside space (3), and at least one inlet opening (4) to the inside space (3) and at least one outlet opening from the inside space (3). A sampling port (5) is provided for allowing access from the outside to the inside space (3), wherein said sampling port (5) is closed by a septum (6) and the septum (6) is separated from the inside space (3) by a barrier wall (7) which is preferably piercable or breakable on application of an external force, preferably applied through a sampling instrument like a needle (8).
Abstract: The invention relates to a liquid-crystalline medium which comprises at least one compound of the formula I, in which R1, R1*, Z1, Z2 and L1-3 have the meanings defined herein, and to the use thereof for an active-matrix display, in particular based on the VA, PSA, PS-VA, PALC, FFS, PS-FFS, PS-IPS or IPS effect.
Type:
Grant
Filed:
October 28, 2016
Date of Patent:
February 19, 2019
Assignee:
MERCK PATENT GMBH
Inventors:
Harald Hirschmann, Monika Bauer, Martina Windhorst, Marcus Reuter, Constanze Brocke, Rocco Fortte, Matthias Bremer, Sabine Schoen
Abstract: The present invention relates to compacted glycine granules, where at least 75% of the granules have a particle size of above 0.7 mm, and to a process for the preparation and use of granules of this type.
Type:
Application
Filed:
January 24, 2017
Publication date:
February 14, 2019
Applicant:
Merck Patent GmbH
Inventors:
Harald BENK, Gudrun BIRK, Melina DECKER, Dieter LUBDA, Guenter MODDELMOG, Harald MUESSIG, Tanino SCARAMUZZA, Michael SCHLEEHAHN
Abstract: The present invention relates to compounds of the formula I and in particular medicaments comprising at least one compound of the formula I for use in the treatment and/or prophylaxis of physiological and/or pathophysiological conditions in the triggering of which cathepsin D is involved, in particular for use in the treatment and/or prophylaxis of arthrosis, traumatic cartilage injuries, arthritis, pain, allodynia or hyperalgesia.